Steven Barth Discusses Regulatory Hurdles for Strategic Buyers
15 October 2024
S&P Global
Foley & Lardner LLP partner Steven Barth commented on the regulatory hurdles strategic buyers face in the S&P Global article, “Private equity fuels TMT M&A for 2nd consecutive quarter in Q3.”
“We live in a current regulatory environment where we can no longer provide reliable advance advice to our clients about whether a deal will likely receive regulatory approval,” Barth explained, highlighting that consequentially, transactional attorneys are emphasizing caution when advising clients.
“We like to be right. And on deals that never get submitted for approval, we’re always right,” Barth added.
Barth’s commentary also appeared in the S&P Global article, “Private equity deals regain momentum; buyout shops lead TMT sector M&A.”
People
Related News
25 October 2024
In the News
Charles Curley and Joshua Ehrenfeld Featured for Arrival to Foley
Foley & Lardner LLP partners Charles Curley and Joshua Ehrenfeld are highlighted across legal press for their recent arrival to the firm.
22 October 2024
In the News
Louis Lehot Publishes on Legal Considerations for Co-Founder Breakups
Foley & Lardner LLP partner Louis Lehot authored The Recorder article, "Co-Founder and Startup Divorce: Hope for the Best, Prepare for the Worst," providing insight on the legal considerations involved in the separation process.
21 October 2024
In the News
David Rosen on FDA GLP-1 Rethink – 'I would call it unprecedented'
Foley & Lardner LLP partner David Rosen discussed the U.S. Food and Drug Administration's approach to GLP-1 compounders in the PharmaVoice article, "FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage."